Navigation Links
Oramed Pharmaceuticals Awarded Grant by the Office of the Chief Scientist of Israel
Date:5/30/2013

JERUSALEM, May 30, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its wholly owned Israeli subsidiary, Oramed Ltd., was awarded a government grant from the Office of the Chief Scientist ("OCS") at the Ministry of Industry, Trade and Labor of Israel.

Nadav Kidron , CEO of Oramed Pharmaceuticals, commented: "We are very pleased that Oramed was recognized as being a competitive developer of innovative oral drug delivery systems for the fourth year in a row. This grant will assist Oramed as we initiate Phase 2 clinical trials in the US on our oral insulin candidate."

The awarded grant amounts to a net sum of NIS 975,000 (approximately US$265,000). Once received, the funds will be designated and used by Oramed Ltd. to support further R&D and clinical studies on its oral insulin capsule (ORMD-0801) and oral exenatide capsule (ORMD-0901) from January 2013 to December 2013. Oramed Ltd. is required to pay royalties in the rate of 3% - 5% on sales of products and services derived from the technology developed using this and other OCS grants until the full dollar amount of the grants are repaid, plus interest. In the absence of such sales, no payment is required.

About The Office of the Chief Scientist

The OCS is the arm of the Israeli government tasked with cultivating the development of industrial R&D within the State of Israel. The mission of the OCS, as defined by the "Law for the Encouragement of Industrial Research and Development-1984," is to assist the advancement of Israel's knowledge-based science and technology industries in order to encourage entrepreneurship and innovative technology development. This support plays a role in stimulating eco
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
2. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
3. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
4. Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials
5. Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
6. Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market
7. Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin
8. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
9. Oramed Submits New IND Application for Oral Insulin Trial in the US
10. Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
11. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... , Sept. 1, 2015  Dr. Cindy ... Labs , the cannabis testing subsidiary of DigiPath, Inc. ... Group about the lack of consistency in today,s ... online resource for medical cannabis information, she explained that ... because their lack of uniform requirements makes standardization impossible. ...
(Date:9/1/2015)... 1, 2015   Millstone Medical Outsourcing announced today ... in Olive Branch, MS. Now totaling ... facility has added the capacity required to meet the ... "This expansion gives us the opportunity to grow in parallel ... Millstone MS. "Two and a half years ago we were ...
(Date:9/1/2015)... 2015   Ivenix Inc. , a medical ... closed on a $42M round of equity financing ... Partners, CICA, Inc., Easterly Capital, Fidelity Biosciences, and ... This financing will support the company,s efforts to ... LLC acted as the exclusive placement agent for ...
Breaking Medicine Technology:DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 2DigiPath Labs CSO Dr. Cindy Orser Calls for Uniform Standards for Cannabis Safety Testing 3Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
(Date:9/2/2015)... ... , ... “ G-Hold ” was featured on NewsWatch as part of its ... Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and ... tablet while reducing the likelihood of it dropping. , Tablets like the iPad and ...
(Date:9/2/2015)... ... September 02, 2015 , ... Pentec Health, Inc., a national ... List for an impressive sixth consecutive year. Less than 5 % of this year’s ... in the “health” sector. Pentec’s 3-year revenue growth rate of 65% sustained its ...
(Date:9/2/2015)... ... September 02, 2015 , ... Mobile working is increasingly more important, as business ... everywhere new mobile apps are being launched, and mobile device usage as a whole ... of their work and personal lives. What's more people are expecting mobile versions of ...
(Date:9/1/2015)... ... September 01, 2015 , ... For many men, the first thing they notice when ... often forced to wear a looser fitting shirt with a collar that doesn’t close against ... finger between their collar and skin all day because it’s uncomfortable. Now men in ...
(Date:9/1/2015)... ... September 02, 2015 , ... The Journal of ... of life, in the USA ”. , As corresponding author Mr Christopher Malone says ... States. In our study, we endeavoured to better understand how migraine headaches impact the ...
Breaking Medicine News(10 mins):Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2
... England star David Beckham is craving for pie and mash, and ... The Scotsman, Becks recently confessed to being homesick following his move ... to be shown on Tuesday at 9 p.m., Becks admits: "Obviously, ... also miss things like English pubs. I will also miss pie ...
... Jordanians and Iraqis, will face prejudice in the wake of ... and Glasgow. ,According to the medical journal ... as an excuse to discriminate against overseas doctors who are ... ,According to a report in the BBC, ...
... research has revealed that four percent of American youths online ... themselves over the Internet. ,Researchers at the ... found that one in 25 youth who use the Internet ... themselves during the course of the year. ,This ...
... Ayurveda, a native system of medicine, has been sentenced to ... for causing the death of a pregnant woman who sought ... ago. ,The doctor had administered some medicines to ... ,According to the prosecution, the deceased, Babli had ...
... Oscar-winning actress Hilary Swank will soon be seen in action spearheading ... their hair as a result of cancer treatment. ... locks, get it cut, and donate it for making wigs for ... ,Swank, who joins the campaign from 2008, will donate her ...
... all right but sans glamorous clothes, high heels and ... women's contest with the aim of reducing infant ... evaluates mothers' weights during pregnancy, the kind of medication ... home. ,The criteria are evaluated by a ...
Cached Medicine News:Health News:Indian, Iraqi Medics may Face Terror Stigma Overseas 2Health News:Four Percent of American Youths are Requested to Post Sexual Snaps on Web 2Health News:Pregnant Women's Contest to Curb Infant Mortality 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: